136 related articles for article (PubMed ID: 37506822)
1. Activation recovery interval as an electrocardiographic repolarization index to detect doxorubicin-induced cardiotoxicity.
Kinoshita T; Onda N; Ohno R; Ikeda T; Sugizaki Y; Ohara H; Nakagami T; Yuzawa H; Shimada H; Shimizu K; Ikeda T
J Cardiol; 2023 Dec; 82(6):473-480. PubMed ID: 37506822
[TBL] [Abstract][Full Text] [Related]
2. Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity.
Kinoshita T; Yuzawa H; Natori K; Wada R; Yao S; Yano K; Akitsu K; Koike H; Shinohara M; Fujino T; Shimada H; Ikeda T
J Cardiol; 2021 Apr; 77(4):388-394. PubMed ID: 33214049
[TBL] [Abstract][Full Text] [Related]
3. Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy-Related Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer.
Yu AF; Moore ZR; Moskowitz CS; Liu JE; Dang CT; Ramanathan L; Oeffinger KC; Steingart RM; Schmitt AM
JAMA Cardiol; 2023 Jul; 8(7):697-702. PubMed ID: 37256614
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms.
Yagi R; Goto S; Himeno Y; Katsumata Y; Hashimoto M; MacRae CA; Deo RC
Nat Commun; 2024 Mar; 15(1):2536. PubMed ID: 38514629
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
[TBL] [Abstract][Full Text] [Related]
6. Early diagnostic value of high-sensitivity cardiac troponin T for cancer treatment-related cardiac dysfunction: a meta-analysis.
Lv X; Pan C; Guo H; Chang J; Gao X; Wu X; Zhi X; Ren C; Chen Q; Jiang H; Zhao X; Liu K; Li Y
ESC Heart Fail; 2023 Aug; 10(4):2170-2182. PubMed ID: 37170474
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
[TBL] [Abstract][Full Text] [Related]
8. Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction.
Okutucu S; Sabanoglu C; Yetis Sayin B; Aksoy H; Bursa N; Oto A
Acta Cardiol; 2020 Feb; 75(1):20-25. PubMed ID: 30513267
[No Abstract] [Full Text] [Related]
9. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity.
Calvillo-Argüelles O; Thampinathan B; Somerset E; Shalmon T; Amir E; Steve Fan CP; Moon S; Abdel-Qadir H; Thevakumaran Y; Day J; Woo A; Wintersperger BJ; Marwick TH; Thavendiranathan P
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1361-1376. PubMed ID: 35926895
[TBL] [Abstract][Full Text] [Related]
10. Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
Tahir E; Azar M; Shihada S; Seiffert K; Goy Y; Beitzen-Heineke A; Molwitz I; Muellerleile K; Stehning C; Schön G; Adam G; Petersen C; Müller V; Lund GK
Eur Radiol; 2022 Mar; 32(3):1853-1865. PubMed ID: 34536111
[TBL] [Abstract][Full Text] [Related]
11. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.
Terui Y; Sugimura K; Ota H; Tada H; Nochioka K; Sato H; Katsuta Y; Fujiwara J; Harada-Shoji N; Sato-Tadano A; Morita Y; Sun W; Higuchi S; Tatebe S; Fukui S; Miyamichi-Yamamoto S; Suzuki H; Yaoita N; Kikuchi N; Sakota M; Miyata S; Sakata Y; Ishida T; Takase K; Yasuda S; Shimokawa H
Int J Cardiol; 2023 Jan; 371():472-479. PubMed ID: 36115441
[TBL] [Abstract][Full Text] [Related]
13. Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied Manifestation.
Peleg Hasson S; Arnold J; Merdler I; Sivan A; Shamai S; Geva R; Merimsky O; Shachar E; Waissengrin B; Moshkovits Y; Arbel Y; Topilsky Y; Rozenbaum Z; Wolf I; Laufer-Perl M
J Immunother; 2021 Jun; 44(5):179-184. PubMed ID: 33950028
[TBL] [Abstract][Full Text] [Related]
14. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
[TBL] [Abstract][Full Text] [Related]
15. Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin.
Lee SH; Cho I; You SC; Cha MJ; Chang JS; Kim WD; Go KY; Kim DY; Seo J; Shim CY; Hong GR; Kang SM; Ha JW; Rha SY; Kim HS
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565449
[TBL] [Abstract][Full Text] [Related]
16. Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study.
Liu J; Cao Y; Zhu K; Yao S; Yuan M; Kong X; Liu X; Li Y; Cui Y; Han X; Zhou X; Meng R; Shi H
Quant Imaging Med Surg; 2022 Oct; 12(10):4771-4785. PubMed ID: 36185042
[TBL] [Abstract][Full Text] [Related]
17. A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer.
Esmaeilzadeh M; Urzua Fresno CM; Somerset E; Shalmon T; Amir E; Fan CS; Brezden-Masley C; Thampinathan B; Thevakumaran Y; Yared K; Koch CA; Abdel-Qadir H; Woo A; Yip P; Marwick TH; Chan R; Wintersperger BJ; Thavendiranathan P
JAMA Cardiol; 2022 Mar; 7(3):330-340. PubMed ID: 35138325
[TBL] [Abstract][Full Text] [Related]
18. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
Veronese P; Hachul DT; Scanavacca MI; Hajjar LA; Wu TC; Sacilotto L; Veronese C; Darrieux FCDC
PLoS One; 2018; 13(5):e0196763. PubMed ID: 29723224
[TBL] [Abstract][Full Text] [Related]
19. Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation.
Moriyama S; Fukata M; Hieda M; Yokoyama T; Yoshimoto G; Kusaba H; Nakashima Y; Miyamoto T; Maruyama T; Akashi K
Open Heart; 2022 May; 9(1):. PubMed ID: 35606045
[TBL] [Abstract][Full Text] [Related]
20. Exercise-induced electrocardiographic changes after treadmill exercise testing in healthy children: A comprehensive study.
Malakan Rad E; Karimi M; Momtazmanesh S; Shabanian R; Saatchi M; Asbagh PA; Zeinaloo AA
Ann Pediatr Cardiol; 2021; 14(4):449-458. PubMed ID: 35527774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
